LEILA FADEL, HOST: The FDA has approved a new drug that appears to slow down Alzheimer's disease.NPR's Jon Hamilton reports.JON HAMILTON, BYLINE: The new drug known as Lecanemab will be marketed under the brand name Leqembi.Maria Carrillo, chief science officer of the Alzheimer's Association, says it could help millions of people in the early stages of the disease.
#people #years #information #essentially #availability #southern-california #predecessor #breakthrough #side-effects #alzheimers-disease
[
add
]
[
|
|
...
]